42Bio Overview

  • Founded
  • 2015
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc

42Bio General Information


Owner and operator of a biomedical technology company intended to address existing barriers to research and clinical translation in tissue engineering and regenerative medicine. The company focuses on combining magnetic nanotechnologies with bio-active molecules and biocompatible materials to make advances in gene transfection, bioreactors, cell and biomolecule separation and cell and tissue culture for regenerative medicine applications, enabling clients to access their technology for processes like lipid extraction and independent flow separation between the tube-side and shell-side flow.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Commercial Products
Other Healthcare Services
Primary Office
  • 10203 South West 49th Lane
  • Gainesville, FL 32608
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

42Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 01-Sep-2018 Completed Generating Revenue
To view 42Bio’s complete valuation and funding history, request access »

42Bio Executive Team (3)

Name Title Board Seat Contact Info
Blanka Sharma Ph.D Co-Founder
Jon Dobson Ph.D Co-Founder
Peter McFetridge Ph.D Co-Founder
To view 42Bio’s complete executive team members history, request access »